Western blot analysis of tumor tissues showed that treatment of ouabain and digoxin sufficiently inhibited expression of CD31, an angiogenesis-related marker, relative to sorafenib treatment in vivo [Fig. 7C]. Here, PECAM1 is linked to neoplasm.